Literature DB >> 18053440

Annual zoledronic acid infusion lowers risk of fracture, death.

Sarah-Anne Schumann1, John Hickner.   

Abstract

Entities:  

Year:  2007        PMID： 18053440      PMCID： PMC3183831     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


× No keyword cloud information.
  6 in total

1.  Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases.

Authors:  Ethel S Siris; Steven T Harris; Clifford J Rosen; Charles E Barr; James N Arvesen; Thomas A Abbott; Stuart Silverman
Journal:  Mayo Clin Proc       Date:  2006-08       Impact factor: 7.616

2.  Effect of hip fracture on mortality in elderly women: the EPIDOS prospective study.

Authors:  Jean-Philippe Empana; Patricia Dargent-Molina; Gérard Bréart
Journal:  J Am Geriatr Soc       Date:  2004-05       Impact factor: 5.562

3.  Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

Authors:  Dennis M Black; Pierre D Delmas; Richard Eastell; Ian R Reid; Steven Boonen; Jane A Cauley; Felicia Cosman; Péter Lakatos; Ping Chung Leung; Zulema Man; Carlos Mautalen; Peter Mesenbrink; Huilin Hu; John Caminis; Karen Tong; Theresa Rosario-Jansen; Joel Krasnow; Trisha F Hue; Deborah Sellmeyer; Erik Fink Eriksen; Steven R Cummings
Journal:  N Engl J Med       Date:  2007-05-03       Impact factor: 91.245

4.  The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies.

Authors:  Cathleen Colón-Emeric; Maragatha Kuchibhatla; Carl Pieper; William Hawkes; Lisa Fredman; Jay Magaziner; Sheryl Zimmerman; Kenneth W Lyles
Journal:  Osteoporos Int       Date:  2003-10-03       Impact factor: 4.507

5.  Hip fracture patients are not treated for osteoporosis: a call to action.

Authors:  J Timothy Harrington; Susan B Broy; Angela M Derosa; Angelo A Licata; David A Shewmon
Journal:  Arthritis Rheum       Date:  2002-12-15

6.  Zoledronic acid and clinical fractures and mortality after hip fracture.

Authors:  Kenneth W Lyles; Cathleen S Colón-Emeric; Jay S Magaziner; Jonathan D Adachi; Carl F Pieper; Carlos Mautalen; Lars Hyldstrup; Chris Recknor; Lars Nordsletten; Kathy A Moore; Catherine Lavecchia; Jie Zhang; Peter Mesenbrink; Patricia K Hodgson; Ken Abrams; John J Orloff; Zebulun Horowitz; Erik Fink Eriksen; Steven Boonen
Journal:  N Engl J Med       Date:  2007-09-17       Impact factor: 91.245
  6 in total
  1 in total

Review 1.  Repurposed and investigational disease-modifying drugs in osteoarthritis (DMOADs).

Authors:  Win Min Oo; David J Hunter
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-05-20       Impact factor: 3.625
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.